Streetbeat News

Stock Prices

COP

Deep-pocketed investors have shown a bearish sentiment towards ConocoPhillips (NYSE:COP) through significant options trading activities. The options scanner highlighted 8 extraordinary options activities, with 62% of the sentiment being bearish. The predicted price range for COP is between $105.0 and $145.0. Analysts maintain positive ratings with an average target price of $152.4.

Portfolio Pulse from Benzinga Insights

May 15, 2024 | 6:48 pm

OXY

Financial giants have shown bullish interest in Occidental Petroleum (NYSE:OXY) through unusual options activity. Analysis reveals 12 unusual trades with a mix of bullish and bearish sentiments. The predicted price range for OXY is between $55.0 and $70.0. Experts have given mixed ratings with an average target price of $74.0.

Portfolio Pulse from Benzinga Insights

May 15, 2024 | 6:48 pm

Benzinga's options scanner identified significant options trading activity on Coca-Cola (NYSE:KO), with a cumulative value of $1,125,070. The trades include both bullish calls and bearish puts, indicating mixed sentiment. Analysts have issued ratings with a consensus target price of $68.8.

Portfolio Pulse from Benzinga Insights

May 15, 2024 | 6:48 pm

CME

KRE

SPY

TAN

Blu Putnam, former chief economist at CME Group, discussed April's inflation report and suggested that the Federal Reserve should cut interest rates based on the Taylor Rule. The CPI numbers showed lower-than-expected inflation growth, sparking a market rally. Despite this, interest rate-sensitive sectors like solar and regional banking ETFs underperformed.

Portfolio Pulse from Aaron Bry

May 15, 2024 | 6:45 pm

AMC

GME

GameStop (GME) and AMC Entertainment (AMC) saw significant gains earlier in the week, causing substantial losses for short sellers. Hedge fund Renaissance Technologies increased its stakes in both companies in Q1, potentially benefiting from the surge. Despite a pullback on Wednesday, GME and AMC shares remain significantly up for the week.

Portfolio Pulse from Adam Eckert

May 15, 2024 | 6:44 pm

AMAT

Stifel analyst Brian Chin reiterated a Buy rating on Applied Materials, Inc. (NASDAQ:AMAT) with a price target of $230. The company will report Q2 FY2024 results on May 16, 2024. The analyst highlights China's significant role in revenue and the potential for higher revenue and profitability in the future.

Portfolio Pulse from Nabaparna Bhattacharya

May 15, 2024 | 6:41 pm

GDRX

GoodRx Holdings Inc. (GDRX) shares surged nearly 10% following the announcement of a new direct contracting agreement with Kroger Co. (KR). The agreement aims to enhance prescription pricing accessibility and affordability across over 2,200 Kroger Family Pharmacy locations. This partnership is expected to deliver nearly 50% more savings on most generics for patients using GoodRx coupons.

Portfolio Pulse from Vaishali Prayag

May 15, 2024 | 6:40 pm

AMZN

NFLX

Amazon has confirmed a live-action Tomb Raider series written by Phoebe Waller-Bridge, along with a new Tomb Raider video game. This announcement was made during Amazon's Upfront event in New York City. Netflix is also developing an animated Tomb Raider series set for release later this year.

Portfolio Pulse from Franca Quarneti

May 15, 2024 | 6:38 pm

NXT

Nextracker Inc. (NASDAQ:NXT) shares surged after the company reported better-than-expected Q4 earnings and revenue. The company posted earnings of 96 cents per share, beating the consensus estimate of 78 cents, and revenue of $736.51 million, surpassing the estimate of $683.43 million. Despite a strong fiscal year 2024, the fiscal year 2025 outlook fell short of analyst expectations. Analysts have mixed reactions, with some lowering their price targets while maintaining positive ratings.

Portfolio Pulse from Erica Kollmann

May 15, 2024 | 6:37 pm

AEMD

ARCO

EDBL

IPW

OPRX

PXLW

VRPX

Gold prices rose over 1% while Arcos Dorados shares fell after Q1 results. U.S. stocks traded higher with the S&P 500 gaining around 1%. Arcos Dorados reported Q1 revenues of $1.081 billion, slightly beating expectations, but missed earnings estimates. OptimizeRx, Edible Garden, and iPower saw significant stock price increases following positive quarterly results. Virpax Pharmaceuticals, Pixelworks, and Aethlon Medical experienced substantial declines due to various negative news.

Portfolio Pulse from Avi Kapoor

May 15, 2024 | 6:33 pm